about
[Lower urinary tract dysfunctions in parkinsonian syndromes: a review by the Neuro-Urology Comittee of the French Association of Urology].[Nitric oxide pathway and female lower urinary tract. Physiological and pathophysiological role].[Multiple sclerosis and pelviperineology: Urinary and sexual dysfunctions and pregnancy].[The impact of mellitus diabetes on the lower urinary tract: A review of Neuro-urology Committee of the French Association of Urology].Sphingosine Kinase 1 urothelial expression is increased in patients with neurogenic detrusor overactivity.Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review.Botulinum toxin-A (Botox) intradetrusor injections in children with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review.Switch to Abobotulinum toxin A may be useful in the treatment of neurogenic detrusor overactivity when intradetrusor injections of Onabotulinum toxin A failed.Outcomes of intra-detrusor injections of botulinum toxin in patients with spina bifida: A systematic review.Predictive model of 1-year postoperative renal function after living donor nephrectomy.Preliminary results of botulinum toxin A switch after first detrusor injection failure as a treatment of neurogenic detrusor overactivity.Assessment of a program to encourage the multidisciplinary management of urinary disorders in multiple sclerosis.Pilot conversion trial from mycophenolic acid to everolimus in ABO-incompatible kidney-transplant recipients with BK viruria and/or viremia.[Tibial nerve transcutaneous stimulation for refractory idiopathic overactive bladder in children and adolescents].[Association of estrogens and selective estrogens receptors modulators: towards a renewal of the hormonal treatment?].[Use of local estrogenotherapy in urology and pelviperineology: A systematic review].[Idiopathic overactive bladder and BOTOX(®): Literature review].Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management: Translation of French recommendations.Three-dimensional laparoscopy for living-donor nephrectomy with vaginal extraction: The first case.[Long-term outcome of patients with renal transplant and neural tube defect].[Epidemiological description of patients with neurological conditions in kidney transplant recipients].[Pathological stage T3 prostate cancer after radical prostatectomy: a retrospective study of 246 cases].[Laparoscopic nephrectomy for polycystic kidneys: principles and results].[Drug therapy of urethral diseases].[Vesicosphincteric and sexual disorders associated with spina bifida and myelomeningocele][Results of a survey on urologic activity in 1-day surgery in Midi-Pyrénées].Vaginal lubrication after cervicovaginal stimulation is facilitated by phosphodiesterase type 5 inhibition in ovariectomized mice.Sacral neuromodulation and pregnancy: Results of a national survey carried out for the neuro-urology committee of the French Association of Urology (AFU).Artificial Urinary Sphincter in Male Patients with Spina Bifida: Comparison of Perioperative and Functional Outcomes between Bulbar Urethra and Bladder Neck Cuff Placement.Estetrol, a Fetal Selective Estrogen Receptor Modulator, Acts on the Vagina of Mice through Nuclear Estrogen Receptor α Activation.Comparison of the effects of β3 -adrenoceptor agonism on urinary bladder function in conscious, anesthetized, and spinal cord injured rats.Reliability of urinary cytology and cystoscopy for the screening and diagnosis of bladder cancer in patients with neurogenic bladder: A systematic review.Efficacy and safety of the first and repeated intradetrusor injections of abobotulinum toxin A 750 U for treating neurological detrusor overactivity.Urinary complications and risk factors in symptomatic multiple sclerosis patients. Study of a cohort of 328 patients.Failures and long-term discontinuations of intradetrusor botulinum toxin injections for neurogenic detrusor overactivity: A new challenge in neurourology.Prospective evaluation of laparoscopic assisted cystectomy and ileal conduit in advanced multiple sclerosis.Prospective study of the impact on quality of life of cystectomy with ileal conduit urinary diversion for neurogenic bladder dysfunction.Comparison of the impact on health-related quality of life of repeated detrusor injections of botulinum toxin in patients with idiopathic or neurogenic detrusor overactivity.Risky business: Adjusting the pressure of the artificial urinary sphincter reservoir.[Epidemiology of emergency consultations for acute urine retention].
P50
Q34643293-D3FD888F-7E3F-4E4A-BCD4-E537FF3BB14AQ34980346-290A9D19-2906-4ADB-BD95-7B2A0978D5A1Q35176089-19DB2F09-83E5-4B48-B644-93CE7A18DB8EQ35802102-25DD5DC1-9A8E-4855-8612-12A46A3BD8DAQ36589246-284C63EE-A02D-462A-8CC7-6CAD16ACE504Q36995681-8C394297-F1D3-490F-A740-0D72ABC0940AQ37407525-A01F1FA8-703F-4FAD-9FED-E490235384E6Q38826378-8AF2C15C-E957-4E75-9142-E2E5E7A8CC46Q38836383-92A1C673-A558-4CFE-A9D3-855DDFD16EA1Q38934323-589B4EC3-0D33-4ECC-9D45-B720C9ACAA71Q39196977-4F1056BB-81C7-42F8-8F41-761F0BEC7CD5Q39877543-B1480B92-79F7-449A-8A79-4DB742C15088Q40907143-C8435915-DDBA-41FB-B353-5495B3D76DF6Q41196817-A497D83C-566C-4BD1-8981-1DFD6724694BQ41478622-6E15E600-9AFF-4549-9344-738022468862Q41483239-F8D6BC47-4CF9-4280-A902-6DCEB815D08AQ41495570-FF6F995D-3BC6-4ABD-A1BE-5FFF1162AEF0Q41741859-3F12EBD6-E105-4AAF-A7F5-18748990FF5EQ42292877-3D0DCBE8-1F12-4523-AF2A-5F04ACC80857Q42718614-915A8034-7EAA-4164-8E0A-1763AF61ABE5Q43588455-A654835D-74B8-4BB6-BF68-A7C0C2BEF413Q44050257-5425D4D4-CA3E-4832-8384-B97681FBC4A9Q44810996-AC8801B6-627B-474C-BEE4-0B44B33ECF3DQ45066132-0F67FD0E-D893-4BEC-8439-2515A50CC966Q45199700-15EA1051-E631-4B25-91A0-95AA8C39F9E3Q45728751-1315C90F-71D4-4CA3-90D6-9579E85C97EAQ45939514-C54934CF-8178-4ADF-A2BC-0204328A4A8FQ47327934-70484E8D-1D03-40F7-BF4E-0365D9F601D8Q47439302-DEDF39DE-82BA-4FBA-918A-7C085A7AD1B7Q47553344-F1F46AC3-6264-4BA4-91CC-A122703789D6Q47856331-08580399-5D2A-4D2C-8715-C5A4735DF76AQ47962090-40CE7AE6-4C73-485C-B43B-062525F795B9Q48075632-4309F5F7-3374-458F-9477-B8E754B196CDQ48154309-83B5E0C6-F76F-434E-9D14-5BE7402BD0DAQ48221855-E634755C-6B8A-49AC-B087-52DC70A95953Q48393880-B23EB622-BDA3-4428-AC4D-15A92046B6A0Q48650075-5A1C21AB-9C9C-46F4-AFEE-09C0F997404CQ48773589-C93DD1AD-89BE-4A48-B345-A4F1D31A855AQ50023120-D7321DC5-4348-497B-92AF-BCC196B6383FQ50033620-4D6033FB-0D9E-4A53-A80A-F9A4EBB4916A
P50
description
researcher ORCID ID = 0000-0001-5353-9008
@en
name
Xavier Gamé
@ast
Xavier Gamé
@en
Xavier Gamé
@es
Xavier Gamé
@nl
type
label
Xavier Gamé
@ast
Xavier Gamé
@en
Xavier Gamé
@es
Xavier Gamé
@nl
prefLabel
Xavier Gamé
@ast
Xavier Gamé
@en
Xavier Gamé
@es
Xavier Gamé
@nl
P1153
7003548587
P31
P496
0000-0001-5353-9008